Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland
Johanna A. Kremer Hovinga(University of Bern), Erika Tarasco(University of Zurich), Heinz Hengartner, Carlo R. Largiadèr(University of Bern), Florian Buchkremer(Kantonsspital Aarau), Behrouz Mansouri Taleghani(University of Bern), Pierre‐Yves Lovey(Hôpital du Valais), Thomas R. Braschler(Luzerner Kantonsspital), Stefan Farese(Solothurner Spitäler)
Cited by 6
Related Papers
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence
|New England Journal of Medicine|2023|128
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
|Archives of Gynecology and Obstetrics|2019|96
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper
|Oncology Research and Treatment|2020|88
Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
|The American Journal of Medicine|2003|72
Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism
|Arteriosclerosis Thrombosis and Vascular Biology|2001|70